Table 2 Characteristics at baseline and during treatment with sacubitril/valsartan
Baseline n = 22 | First year n = 17 | Second year n = 13 | |
|---|---|---|---|
Serum creatinine, mg/dL | 2.2 ± 0.6 | 1.9 ± 0.5 | 1.7 ± 0.4 |
eGFR, mL/min/1.73m2 | 29.4 ± 8.3 | 35.8 ± 9.4 | 39.8 ± 12.0 |
Potassium, mEq/L | 4.61 ± 0.6 | 4.90 ± 0.6 | 4.87 ± 0.6 |
Urine protein:creatinine, mg/g | 56.4 (26.3–427) | 165 (100–313) | 264 (51.3–1007.9) |
Systolic blood pressure, mmHg | 129.1 ± 20.2 | 124.2 ± 17.3 | 123.0 ± 18.1 |
Diastolic blood pressure, mmHg | 70.2 ± 14.9 | 72.4 ± 11.0 | 70.4 ± 11.6 |
LVEF, % | 36.4 ± 8.9 | 39.6 ± 10.2 | 38.8 ± 8.8 |
Visits to ED, number | 1(0–2) | 0 (0–0.3) | 0 (0–0) |